BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$23.00 USD
+0.12 (0.52%)
Updated Aug 7, 2024 09:56 AM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Brokerage Reports
BioLife Solutions, Inc. [BLFS]
Reports for Purchase
Showing records 1 - 20 ( 91 total )
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Life Science Technology: Today''s FDA Approvals Setting CGT Record - Tool Beneficiary Overview
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
3Q23 as Expected with Asset Sale into 2024
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
CEO Change to Long-Time Operator Seems Like Efficient Pathway to Value Creation
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
2Q23 - Pro Forma Look Cell Therapy Pure Play in 2024-2025
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Cryoport Lowers Guidance: Implications for CGT Players
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
1Q Light, but Freeze Thaw ''Strategic Review'' Very Positive Move
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
4Q22 - Margin Expansion Comes into Clear View
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Risk Factors for Life Science May Be de Minimis
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
JPM Takeaways, Positive Industry Backdrop for 2023
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Positive Announcements Rolling Out at JPM
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department